FGF4 and breast carcinoma: The tumor growth-suppressing and anti-metastatic actions of BMTP78 were revealed for murine breast carcinomas 4T1 and EF43-fgf4 in vivo as well as for human triple negative breast cancer MDA-MB-231 xenografts in mice [128].